Sharing expertise to strengthen malaria vaccine safety monitoring

The ReSaG (Regional Safety Group) is a community of experts coordinated by the Rabat Collaborating Center (RCC) through the OPT-MVAC consortium. Its objective is to strengthen the analysis and interpretation of pharmacovigilance data for the RTS,S and R21 malaria vaccines across 14 partner countries in West and Central Africa.

The group brings together representatives from pharmacovigilance centres, malaria control programmes and immunisation programmes, alongside clinical experts. Its mandate includes analysing adverse events following immunisation (AEFIs), case clusters and potential safety signals, as well as providing expert advice and proposing risk-minimisation measures.

To date, three ReSaG meetings have been held (out of nine planned for the 2025–2028 period) in addition to a special session focused on rumours and communication. These meetings have facilitated the sharing of pharmacovigilance data, the review of serious cases and the exchange of experiences among partner countries. Discussions highlighted shared priorities: reducing under-reporting, improving data quality, strengthening the investigation of serious cases and documenting causality assessments. ReSaG meetings have also underscored the importance of close coordination among the three relevant country programmes, greater country involvement in analyses and the provision of support tailored to specific needs, particularly regarding the use of digital tools and capacity strengthening.

The special ReSaG session provided an opportunity to share experiences from Togo, Ghana and Côte d’Ivoire regarding the management of rumours and disinformation. It emphasised the value of social listening, transparent communication, community engagement and collaboration with OPT-MVAC’s workstream on communications to prevent misinformation and maintain public trust in vaccines. Complementing the ongoing monitoring conducted through the consortium’s workstream on safety and pharmacovigilance for malaria vaccines, ReSaG serves as a forum for sharing expertise, harmonising practices and formulating recommendations to strengthen vaccine safety and national pharmacovigilance systems.

Watch the previous ReSaG meetings: 

ReSaG 1: Rumours and communication
ReSaG 2: Pharmacovigilance and surveillance of AEFIs related to malaria vaccines
ReSaG 3: Strengthening pharmacovigilance systems to support malaria vaccine rollout

 

Share this article:

Please fill in the details below to complete your subscription